Hadasit Bio-Holdings
Overview
Hadasit Bio-Holdings Ltd. is a publicly traded subsidiary (OTCBB: HADSY) of the Hadassah University Hospital, Israel's foremost medical research center, promoting medical breakthroughs. HadasitBio focuses on supporting its portfolio companies as they advance towards Phase II clinical trials and general assistance including pre-clinical trials, manufacturing, regulatory and business development tasks.
Reach Hadasit Bio-Holdings directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Hadasit Bio-Holdings
What stage does Hadasit Bio-Holdings invest at?
Hadasit Bio-Holdings backs companies at Seed and Series A.
How do I contact Hadasit Bio-Holdings?
Hadasit Bio-Holdings's contact details — including phone and LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of the team.
Last updated · Source: ConnectSafely investor database
